MicroRNA106a regulates matrix metalloprotease 9 in a sirtuin-1 dependent mechanism.

about

MicroRNA106a regulates matrix metalloprotease 9 in a sirtuin-1 dependent mechanism.

Item

http://www.wikidata.org/entity/Q48199462

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

MicroRNA106a regulates matrix metalloprotease 9 in a sirtuin-1 dependent mechanism.

@en

MicroRNA106a regulates matrix metalloprotease 9 in a sirtuin-1 dependent mechanism.

@nl

type

Item

label

MicroRNA106a regulates matrix metalloprotease 9 in a sirtuin-1 dependent mechanism.

@en

MicroRNA106a regulates matrix metalloprotease 9 in a sirtuin-1 dependent mechanism.

@nl

prefLabel

MicroRNA106a regulates matrix metalloprotease 9 in a sirtuin-1 dependent mechanism.

@en

MicroRNA106a regulates matrix metalloprotease 9 in a sirtuin-1 dependent mechanism.

@nl

P1476

MicroRNA106a regulates matrix metalloprotease 9 in a sirtuin-1 dependent mechanism.

@en

P2093

Ashutosh K Maurya

http://www.w3.org/2001/XMLSchema#string

Grace Raji

http://www.w3.org/2001/XMLSchema#string

Haritha Kunhiraman

http://www.w3.org/2001/XMLSchema#string

Lincy Edatt

http://www.w3.org/2001/XMLSchema#string

P2860

MicroRNAs and metastasis: little RNAs go a long way

MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis

Emerging features in the regulation of MMP-9 gene expression for the development of novel molecular targets and therapeutic strategies

A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation

New functions for the matrix metalloproteinases in cancer progression

Dissemination and growth of cancer cells in metastatic sites

Matrix metalloproteinases: regulators of the tumor microenvironment

Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential.

TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3.

Sirt1, a negative regulator of matrix metalloproteinase-9 in diabetic retinopathy.

P304

238-248

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCP.25870

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

233

http://www.w3.org/2001/XMLSchema#string

P50

V B Sameer Kumar

P577

2017-02-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28233301

http://www.w3.org/2001/XMLSchema#string